Mr. Tomasello is managing director of iNetworks, LLC. Previously, he had retired as Executive Vice President and Chief Technical Officer of Stericycle, Inc., a publicly traded company on the NASDAQ exchange (SRCL). Stericycle specializes exclusively in regulated services to the healthcare community. Mr. Tomasello joined Stericycle in its infancy as a venture capital start-up funded with $200,000 of seed capital. He subsequently led the effort of developing and commercializing its intellectual property and operations, both domestically and internationally. During the time that he spent as a member of the executive officer team, he was instrumental in Stericycle’s growth to its current position as the world’s leader in its field with $2 billion in sales and a current enterprise value of more than $10 Billion and more than 10,000 full time employees. Immediately prior to his association with Stericycle, Mr. Tomasello founded, grew, and then subsequently sold a specialist consulting engineering firm. He is the holder of multiple domestic and international patents. Mr. Tomasello is a graduate of the University of Pittsburgh in Mechanical Engineering.

Additionally, he has both public and private board experience. Mr. Tomasello was recently a member of the Board of Directors of a joint venture company with the University of Utah to commercialize technologies issuing from the University staff. He also sits on the Merrill Lynch/Bank of America Advisory Board.

Mr. Appelbaum has more than 25 years of life sciences & biotech experience, including business development, marketing, sales, and management. He was appointed President & CEO of Novian Health in 2005 and has led the development of an image-guided, laser ablation therapy for treating tumors. He has successfully raised over $20 million and led the development of Novian’s manufacturing operations.

Previously, Chip spent five years as Vice President of Corporate Development at Source Precision Medicine, a molecular diagnostics startup he helped found and nine years at Amgen where he managed the business development department and then led the Infergen® launch team. Prior to Amgen, he served in a technology transfer role at Argonne National Laboratory and conducted contract research at Battelle. He holds an MBA from the University of Chicago and an S.M. in Chemical Engineering from MIT.

Steve Bonner served as the Chief Executive Officer and President of Cancer Treatment Centers of America, Inc. from 1999 until 2013. In 2013 he assumed the new role as Executive Chairman for CTCA and completed his role as a CTCA Executive in February of 2014. In 2014 Steve accepted a four-year appointment as an Entrepreneur in Residence at Harvard Business School’s Rock Center for Entrepreneurial Studies. He mentored students on healthcare, health policy, and health care innovation, and helped teach a second year MBA course on Innovation in Healthcare.

Prior to CTCA, Steve served as an Executive Vice President of Keyport Insurance Company where he led the development of a new annuity market. Before that he served as the President of the Construction Information Group of the McGraw-Hill Companies and as a Vice President of The Prudential Insurance Company of America, where he started the consumer banking units and led the marketing of annuities through external channels.

Steve is a longtime advocate for consumer-centric, quality-driven healthcare transformation that empowers patients with clear and thorough information and puts them at the center of their medical decisions. In 2012, Steve was named one of the 100 Most Influential People in Healthcare by Modern Healthcare.

Steve graduated from Amherst College and has a law degree from William Mitchell College of Law.

Anthony Lacenere, co-founder of iNetworks, LLC, provides leadership focused on cash-on-cash returns, based on an extensive experience portfolio in venture capital and private equity investing, medical device and other biomedical technology, and company operations. Prior to iNetworks, Mr. Lacenere was President of MDX Oncology, Inc., affiliated with Universal Health Services (UHS) of King of Prussia, PA, advising UHS with respect to its oncology-related investments and operations, including imaging, diagnostics and therapeutic projects. Prior to MDX, Mr. Lacenere was a principal on a management team in a leveraged buyout of American Sterilizer Company, a $300 million New York Stock Exchange listed company. As a principal of the buyout group, and the group’s dealmaker, he completed numerous transactions in the US, Europe and Asia.

A dual citizen of the United States and Italy, Mr. Lacenere is a member of the International Parents Council of McGill University, Montreal, Quebec. Mr. Lacenere holds an M.S. in Business Economics from Ohio State University (Graduate Research Fellow with Distinction) and a B.S. in Economics and Finance from the University of Dayton.

John Regan is Managing Director at Energy Foundry, a Chicago based venture capital firm. He has more than 25 years of experience in the industry and has played key roles in early stage venture capital.

Prior to joining Energy Foundry, John was a Managing Director at Illinois Ventures, and is a founding member of the Illinois Emerging Technology Funds. His portfolio investments won numerous awards including MIT top 10 Technologies, EPA Product of the year and WSJ Annual Technology Innovation Award. While there, he helped grow the firm from start-up to $70 million under management.

Earlier in his career, John was Managing Director of Keystone Venture Capital and was the lead investor in several transactions as well as an active board member. Several of John’s investments were acquired or went public including CDNow.com, VST Technologies, Imaging Automation, Arnold Palmer Golf and EnvestNet.

John was an early member of Apex Venture Partners and made numerous investments including a manufacturer and specialty retailer, which grew over $200 million in revenue and a successful IPO. He started his career at General Dynamics where he received an Educational Fellowship, Emerald Recognition Award and held a top secret clearance.

John received a MBA from the University of Chicago. He also holds a MS and BS in General Engineering from the University of Illinois at Urbana-Champaign.